PDCD1 and neoplasm: Binding of PD-L1 with PD-1 on activated T cells blocks PI3K and Akt activity, disrupts glucose metabolism and suppresses Th1 cytokines production, which could induce effector T cells dysfunction, exhaustion and protect tumor cells from being killed by CD8+ T cells (cytotoxic T cells) (71, 72).